Immune Response Modifications in the Genetic Forms of Parkinson's Disease: What Do We Know?

Int J Mol Sci. 2022 Mar 23;23(7):3476. doi: 10.3390/ijms23073476.

Abstract

Parkinson's disease (PD) is a common neurodegenerative disease characterized by loss of dopaminergic neurons in the pars compacta of the midbrain substantia nigra. PD pathophysiology is complex, multifactorial, and not fully understood yet. Nonetheless, recent data show that immune system hyperactivation with concomitant production of pro-inflammatory cytokines, both in the central nervous system (CNS) and the periphery, is a signature of idiopathic PD. About 5% of PD patients present an early onset with a determined genetic cause, with either autosomal dominant or recessive inheritance. The involvement of immunity in the genetic forms of PD has been a matter of interest in several recent studies. In this review, we will summarize the main findings of this new and promising field of research.

Keywords: Parkinson’s disease; alpha-synuclein; immune system.

Publication types

  • Review

MeSH terms

  • Dopaminergic Neurons / metabolism
  • Humans
  • Immunity
  • Neurodegenerative Diseases*
  • Parkinson Disease* / genetics
  • Substantia Nigra / metabolism
  • alpha-Synuclein / metabolism

Substances

  • alpha-Synuclein